Digestive & Gut Support Because BPC-157 originates from a protective stomach compound, researchers have also explored its possible role in supporting the digestive tract, gut lining, and gastrointestinal wellness
As of 2026, cagrilintide is not FDA approved for any indication
Counteracts NSAID Damage BPC-157 has been uniquely shown to reverse the gastrointestinal damage caused by NSAIDs (ibuprofen, naproxen, aspirin)
Mild side effects may include slight redness or tenderness at the injection site, but these usually resolve quickly.
This 60% reduction coincides with observable decreases in regenerative capacity, wound healing efficiency, and overall tissue maintenance
Every step should reduce local stress inside the vial